Relationship between Vitamin D Status and Autonomic Nervous System Activity

Morton G Burt, Brenda L Mangelsdorf, Stephen N Stranks, Arduino A Mangoni, Morton G Burt, Brenda L Mangelsdorf, Stephen N Stranks, Arduino A Mangoni

Abstract

Vitamin D deficiency is associated with increased arterial stiffness. However, the mechanisms underlying this association have not been clarified. The aim was to investigate whether changes in autonomic nervous system activity could underlie an association between 25 hydroxy vitamin D and arterial stiffness. A total of 49 subjects (age = 60 ± 8 years, body mass index = 26.7 ± 4.6 kg/m², 25 hydroxy vitamin D = 69 ± 22 nmol/L) underwent measurements of pulse wave velocity (PWV) and augmentation index (AIx), spontaneous baroreflex sensitivity, plasma metanephrines and 25 hydroxy vitamin D. Subjects with 25 hydroxy vitamin D ≤ 50 nmol/L were restudied after 200,000 International Units 25 hydroxy vitamin D. Plasma metanephrine was positively associated with AIx (p = 0.02) independent of age, sex, smoking and cholesterol and negatively associated with 25 hydroxy vitamin D (p = 0.002) independent of age, sex and season. In contrast, there was no association between baroreflex sensitivity and 25 hydroxy vitamin D (p = 0.54). Treatment with vitamin D increased 25 hydroxy vitamin D from 43 ± 5 to 96 ± 24 nmol/L (p < 0.0001) but there was no significant change in plasma metanephrine (115 ± 25 vs. 99 ± 39 pmol/L, p = 0.12). We conclude that as plasma metanephrine was negatively associated with 25 hydroxy vitamin D and positively with AIx, it could mediate an association between these two variables. This hypothesis should be tested in larger interventional studies.

Keywords: 25 hydroxy vitamin D; augmentation index; baroreflex sensitivity; metanephrine; pulse wave velocity.

Conflict of interest statement

The authors declare no conflict of interest. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.

Figures

Figure 1
Figure 1
Simple linear regression relationship between serum 25 hydroxy vitamin D and plasma metanephrine in 43 subjects.

References

    1. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., Kinkeldei J., Boehm B.O., Weihrauch G., Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 2008;168:1340–1349. doi: 10.1001/archinte.168.12.1340.
    1. Tomson J., Emberson J., Hill M., Gordon A., Armitage J., Shipley M., Collins R., Clarke R. Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. Eur. Heart J. 2013;34:1365–1374. doi: 10.1093/eurheartj/ehs426.
    1. Perna L., Schottker B., Holleczek B., Brenner H. Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: A prospective study with repeated measurements. J. Clin. Endocrinol. Metab. 2013;98:4908–4915. doi: 10.1210/jc.2013-2424.
    1. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010;55:1318–1327. doi: 10.1016/j.jacc.2009.10.061.
    1. Vlachopoulos C., Aznaouridis K., O'Rourke M.F., Safar M.E., Baou K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: A systematic review and meta-analysis. Eur. Heart J. 2010;31:1865–1871. doi: 10.1093/eurheartj/ehq024.
    1. Al Mheid I., Patel R., Murrow J., Morris A., Rahman A., Fike L., Kavtaradze N., Uphoff I., Hooper C., Tangpricha V., et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J. Am. Coll. Cardiol. 2011;58:186–192. doi: 10.1016/j.jacc.2011.02.051.
    1. Mayer O., Jr., Filipovsky J., Seidlerova J., Vanek J., Dolejsova M., Vrzalova J., Cifkova R. The association between low 25-hydroxyvitamin D and increased aortic stiffness. J. Hum. Hypertens. 2012;26:650–655. doi: 10.1038/jhh.2011.94.
    1. Giallauria F., Milaneschi Y., Tanaka T., Maggio M., Canepa M., Elango P., Vigorito C., Lakatta E.G., Ferrucci L., Strait J. Arterial stiffness and vitamin D levels: The Baltimore longitudinal study of aging. J. Clin. Endocrinol. Metab. 2012;97:3717–3723. doi: 10.1210/jc.2012-1584.
    1. Wilkinson I.B., Franklin S.S., Cockcroft J.R. Nitric oxide and the regulation of large artery stiffness: From physiology to pharmacology. Hypertension. 2004;44:112–116. doi: 10.1161/01.HYP.0000138068.03893.40.
    1. Lim S., Shin H., Kim M.J., Ahn H.Y., Kang S.M., Yoon J.W., Choi S.H., Kim K.W., Song J.H., Choi S.I., et al. Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: The Korean Longitudinal Study on Health and Aging. J. Clin. Endocrinol. Metab. 2012;97:169–178. doi: 10.1210/jc.2011-1580.
    1. De Boer I.H., Kestenbaum B., Shoben A.B., Michos E.D., Sarnak M.J., Siscovick D.S. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J. Am. Soc. Nephrol. 2009;20:1805–1812. doi: 10.1681/ASN.2008111157.
    1. Michos E.D., Streeten E.A., Ryan K.A., Rampersaud E., Peyser P.A., Bielak L.F., Shuldiner A.R., Mitchell B.D., Post W. Serum 25-hydroxyvitamin D levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish. Calcif. Tissue Int. 2009;84:195–202. doi: 10.1007/s00223-008-9209-3.
    1. Mangoni A.A., Mircoli L., Giannattasio C., Mancia G., Ferrari A.U. Effect of sympathectomy on mechanical properties of common carotid and femoral arteries. Hypertension. 1997;30:1085–1088. doi: 10.1161/01.HYP.30.5.1085.
    1. La Rovere M.T., Bigger J.T., Jr., Marcus F.I., Mortara A., Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478–484. doi: 10.1016/S0140-6736(97)11144-8.
    1. Mann M.C., Exner D.V., Hemmelgarn B.R., Sola D.Y., Turin T.C., Ellis L., Ahmed S.B. Vitamin D levels are associated with cardiac autonomic activity in healthy humans. Nutrients. 2013;5:2114–2127. doi: 10.3390/nu5062114.
    1. Mann M.C., Exner D.V., Hemmelgarn B.R., Turin T.C., Sola D.Y., Ellis L., Ahmed S.B. Vitamin D supplementation is associated with improved modulation of cardiac autonomic tone in healthy humans. Int. J. Cardiol. 2014;172:506–508. doi: 10.1016/j.ijcard.2014.01.058.
    1. Puchacz E., Stumpf W.E., Stachowiak E.K., Stachowiak M.K. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res. Mol. Brain Res. 1996;36:193–196. doi: 10.1016/0169-328X(95)00314-I.
    1. Mann M.C., Hollenberg M.D., Hanley D.A., Ahmed S.B. Vitamin D, the autonomic nervous system, and cardiovascular risk. Physiol. Rep. 2015;3:e12349. doi: 10.14814/phy2.12349.
    1. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Investig. 2002;110:229–238. doi: 10.1172/JCI0215219.
    1. Burt M.G., Mangelsdorf B.L., Srivastava D., Petersons C.J. Acute effect of calcium citrate on serum calcium and cardiovascular function. J. Bone Miner Res. 2013;28:412–418. doi: 10.1002/jbmr.1761.
    1. Petersons C.J., Mangelsdorf B.L., Thompson C.H., Burt M.G. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency. J. Clin. Endocrinol. Metab. 2014;99:2269–2276. doi: 10.1210/jc.2013-4305.
    1. Clarke M.W., Cooke B., Hoad K., Glendenning P. Improved plasma free metadrenaline analysis requires mixed mode cation exchange solid-phase extraction prior to liquid chromatography tandem mass spectrometry detection. Ann. Clin. Biochem. 2011;48:352–357. doi: 10.1258/acb.2011.010235.
    1. Aydemir M., Yazisiz V., Basarici I., Avci A.B., Erbasan F., Belgi A., Terzioglu E. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus. 2010;19:255–261. doi: 10.1177/0961203309351540.
    1. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., Pannier B., Vlachopoulos C., Wilkinson I., Struijker-Boudier H. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur. Heart J. 2006;27:2588–2605. doi: 10.1093/eurheartj/ehl254.
    1. Parati G., Di Rienzo M., Mancia G. How to measure baroreflex sensitivity: From the cardiovascular laboratory to daily life. J. Hypertens. 2000;18:7–19. doi: 10.1097/00004872-200018010-00003.
    1. Eisenhofer G., Rundquist B., Aneman A., Friberg P., Dakak N., Kopin I.J., Jacobs M.C., Lenders J.W. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J. Clin. Endocrinol. Metab. 1995;80:3009–3017.
    1. Kruse H.J., Wieczorek I., Hecker H., Creutzig A., Schellong S.M. Seasonal variation of endothelin-1, angiotensin II, and plasma catecholamines and their relation to outside temperature. J. Lab. Clin. Med. 2002;140:236–241. doi: 10.1067/mlc.2002.127169.
    1. Pamporaki C., Bursztyn M., Reimann M., Ziemssen T., Bornstein S.R., Sweep F.C., Timmers H., Lenders J.W., Eisenhofer G. Seasonal variation in plasma free normetanephrine concentrations: Implications for biochemical diagnosis of pheochromocytoma. Eur. J. Endocrinol. 2014;170:349–357. doi: 10.1530/EJE-13-0673.
    1. Beveridge L.A., Struthers A.D., Khan F., Jorde R., Scragg R., Macdonald H.M., Alvarez J.A., Boxer R.S., Dalbeni A., Gepner A.D., et al. Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data. JAMA Intern. Med. 2015;175:745–754. doi: 10.1001/jamainternmed.2015.0237.
    1. Stamatelopoulos K., Athanasouli F., Pappa T., Labrinoudaki I., Papamichael C., Polymeris A., Georgiopoulos G., Vemmou A., Sarika L., Terpos E., et al. Hemodynamic markers and subclinical atherosclerosis in postmenopausal women with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 2014;99:2704–2711. doi: 10.1210/jc.2013-4273.
    1. Darr R., Pamporaki C., Peitzsch M., Miehle K., Prejbisz A., Peczkowska M., Weismann D., Beuschlein F., Sinnott R., Bornstein S.R., et al. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: Importance of supine sampling under fasting conditions. Clin. Endocrinol. (Oxf.) 2014;80:478–486. doi: 10.1111/cen.12327.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj